Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection.Helicobacter. 2007; 12: 1-15
- Gastric cancer susceptibility is not linked to pro- and anti-inflammatory cytokine gene polymorphisms in whites: a Nationwide Multicenter Study in Spain.Am J Gastroenterol. 2007; 102: 1878-1892
- Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa.J Infect Dis. 2003; 188: 272-281
- Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma.Gastroenterology. 2001; 121: 823-829
- Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.BMJ. 1991; 302: 1302-1305
- Epidemiology and pathogenesis of esophageal cancer.Semin Radiat Oncol. 2007; 17 ([review]): 2-9
- Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study.Hum Pathol. 2001; 32: 379-388
- Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.CA Cancer J Clin. 2011; 61: 212-236
- Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram.Ann Surg. 2010; 251: 640-646
- Epithelial neoplasms of the stomach.in: Odze R.D. Goldblum J.R. Surgical pathology of the GI tract, liver, biliary tract and pancreas. Saunders Elsevier, Philadelphia, PA2009: 563-579
- Genetic clonal diversity predicts progression to esophageal adenocarcinoma.Nat Genet. 2006; 38: 468-473
- Helicobacter pylori and gastric carcinogenesis.Am J Surg Pathol. 1995; 19: S37-S43
- Human gastric carcinogenesis: a multistep and multifactorial process–First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention.Cancer Res. 1992; 52: 6735-6740
- A model for gastric cancer epidemiology.Lancet. 1975; 2: 58-60
- Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis.Cancer Causes Control. 2011; 22: 375-387
- Understanding the genetic basis of gastric cancer: recent advances.Expert Rev Gastroenterol Hepatol. 2012; 6: 335-341
- Interleukin-1 polymorphisms associated with increased risk of gastric cancer.Nature. 2000; 404: 398-402
- Polymorphisms in inflammatory response genes and their association with gastric cancer: a HuGE systematic review and meta-analyses.Am J Epidemiol. 2011; 173: 259-270
- 17q12-21 amplicon, a novel recurrent genetic change in intestinal type of gastric carcinoma: a comparative genomic hybridization study.Genes Chromosomes Cancer. 1997; 20: 38-43
- Correlation of histologic subtypes and replication error phenotype with comparative genomic hybridization in gastric cancer.Genes Chromosomes Cancer. 2001; 30: 80-86
- Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival.Cell Oncol. 2004; 26: 307-317
- Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer.J Pathol. 2008; 216: 471-482
- Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer.Cancer Res. 1993; 53: 5087-5089
- Distinct clinical features and outcomes of gastric cancers with microsatellite instability.Mod Pathol. 2002; 15: 632-640
- Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers.Surgery. 2006; 139: 347-356
- Clinicopathologic characteristics and outcomes of gastric cancers with the MSI-H phenotype.J Surg Oncol. 2009; 99: 143-147
- Correlation of microsatellite instability at multiple loci with long-term survival in advanced gastric carcinoma.Arch Surg. 2009; 144: 722-727
- Analysis of microsatelliteinstability, protein expression and methylation status of hMLH1 and hMSH2 genes in gastric carcinomas.Hepatogastroenterology. 2009; 56: 899-904
- Molecular-pathological prognostic factors of gastric cancer: a review.Gastric Cancer. 2005; 8: 86-94
- Age-related hypermethylation of the hMLH1 promoter in gastric cancers.Int J Cancer. 2001; 94: 208-211
- Microsatellite instability of papillary subtype of human gastric adenocarcinoma and hMLH1 promoter hypermethylation in the surrounding mucosa.Pathol Int. 2001; 51: 240-247
- Genomic dysregulation in gastric tumors.J Surg Oncol. 2013; 107: 237-242
- Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial.J Clin Oncol. 2012; 30: 2119-2127
- HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target.Ann Oncol. 2008; 19: 1523-1529
- HER2 expression in gastric cancer in Peru.Rev Gastroenterol Peru. 2010; 30 ([in Spanish]): 324-327
- Assessment of a HER2 scoring system for gastric cancer: results from a validation study.Histopathology. 2008; 52: 797-805
- Clinicopathologic characteristics of patients with stage III/IV (M(0)) advanced gastric cancer, according to HER2 status assessed by immunohistochemistry and fluorescence in situ hybridization.Diagn Mol Pathol. 2011; 20: 94-100
- Amplification of HER-2 in gastric carcinoma: association with Topoisomerase II alpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.Ann Oncol. 2005; 16: 273-278
- HER2 testing in gastric cancer.Adv Anat Pathol. 2011; 18: 53-59
- ToGA Trial Investigators. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.Lancet. 2010; 376: 687-697
- Advances in the management of HER2-positive advanced gastric and gastroesophageal junction cancer.J Clin Gastroenterol. 2012; 46: 637-648
Herceptin summary of product characteristics. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_Product_Information/human/000278/WC500074922.pdf. Accessed September 22, 2011.
Powell WC, Zielinski D, Ranger-Moore J, et al. Determining the HER2 status in gastric cancer: a method comparison study of two patient cohorts. ASCO Gastrointestinal Cancers Symposium. Orlando, January 22–24, 2010 [abstract 17].
NCCN clinical practice guidelines in oncology (NCCN guidelines). Gastric Cancer. Version 2.2011. Available at: http://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf. Accessed September 22, 2011.
- Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness.Biochim Biophys Acta. 1994; 1198: 11-26
- The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene.Trends Biochem Sci. 1999; 24: 73-76
- Soluble E-cadherin is a valid prognostic marker in gastric carcinoma.Gut. 2001; 48: 808-811
- The cooperative role of p27 with cyclin E in the prognosis of advanced gastric carcinoma.Cancer. 2000; 89: 1214-1219
- p53 and VEGF expression are independent predictors of tumor recurrence and survival following curative resection of gastric cancer.Br J Cancer. 2004; 90: 206-215
- Clinicopathological significance and survival influence of p53 protein expression in gastric carcinoma.Histopathology. 2004; 44: 323-331
- Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.N Engl J Med. 2006; 355: 11-20
- Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.N Engl J Med. 2001; 345: 725-730
- Nature meets nurture: molecular genetics of gastric cancer.Hum Genet. 2009; 126: 615-628https://doi.org/10.1007/s00439-009-0722-x
- The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo- clinical classification.Acta Pathol Microbiol Scand. 1965; 64: 31-49
- Genetic aspects of gastric cancer instability.ScientificWorldJournal. 2012; 2012: 761909
- Epithelial neoplasms of the esophagus.in: Odze R.D. Goldblum J.R. Surgical pathology of the GI tract, liver, biliary tract and pancreas. Saunders Elsevier, Philadelphia, PA2009: 535-562
Article info
Publication history
Published online: October 17, 2013
Identification
Copyright
© 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
